KEY FACTORS FOR SUCCESSFUL GENERATION OF PROTEIN-FRAGMENT STRUCTURES: REQUIREMENT ON PROTEIN, CRYSTALS, AND TECHNOLOGY

被引:14
作者
Boettcher, Jark [1 ]
Jestel, Anja [1 ]
Kiefersauer, Reiner [1 ]
Krapp, Stephan [1 ]
Nagel, Susanna [1 ]
Steinbacher, Stefan [1 ]
Steuber, Holger [1 ]
机构
[1] Proteros Biostruct GmbH, Martinsried, Germany
来源
FRAGMENT-BASED DRUG DESIGN: TOOLS, PRACTICAL APPROACHES, AND EXAMPLES | 2011年 / 493卷
关键词
X-RAY CRYSTALLOGRAPHY; STRUCTURE-BASED DESIGN; TYROSINE-PHOSPHATASE; 1B; NITRIC-OXIDE SYNTHASE; LEAD DISCOVERY; DRUG DESIGN; BETA-SECRETASE; KINASE INHIBITORS; LIGAND-BINDING; ACTIVE-SITE;
D O I
10.1016/B978-0-12-381274-2.00003-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In the past two decades, fragment-based approaches have evolved as a predominant strategy in lead discovery. The availability of structural information on the interaction geometries of binding fragments is key to successful structure-guided fragment-to-lead evolution. In this chapter, we illustrate methodological advances for protein fragment crystal structure generation in order to offer general lessons on the importance of fragment properties and the most appropriate crystallographic setup to evaluate them. We analyze elaborate protocols, methods, and clues applied to challenging complex formation projects. The results should assist medicinal chemists to select the most promising targets and strategies for fragment-based crystallography as well as provide a tutorial to structural biologists who attempt to determine protein-fragment structures.
引用
收藏
页码:61 / 89
页数:29
相关论文
共 102 条
  • [1] 2-(Oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatases
    Andersen, HS
    Iversen, LF
    Jeppesen, CB
    Branner, S
    Norris, K
    Rasmussen, HB
    Moller, KB
    Moller, NPH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (10) : 7101 - 7108
  • [2] Cross-linking of protein crystals as an aid in the generation of binary protein-ligand crystal complexes, exemplified by the human PDE10a-papaverine structure
    Andersen, Ole Andreas
    Schoenfeld, Dorian Leo
    Toogood-Johnson, Ian
    Felicetti, Brunella
    Albrecht, Claudia
    Fryatt, Tara
    Whittaker, Mark
    Hallett, David
    Barker, John
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2009, 65 : 872 - 874
  • [3] Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitors
    Anderson, Malcolm
    Andrews, David M.
    Barker, Andy J.
    Brassington, Claire A.
    Breed, Jason
    Byth, Kate F.
    Culshaw, Janet D.
    Finlay, M. Raymond V.
    Fisher, Eric
    McMiken, Helen H. J.
    Green, Clive P.
    Heaton, Dave W.
    Nash, Ian A.
    Newcombe, Nicholas J.
    Oakes, Sandra E.
    Pauptit, Richard A.
    Roberts, Andrew
    Stanway, Judith J.
    Thomas, Andrew P.
    Tucker, Julie A.
    Walker, Mike
    Weir, Hazel M.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (20) : 5487 - 5492
  • [4] Fragment-based discovery of JAK-2 inhibitors
    Antonysamy, Stephen
    Hirst, Gavin
    Park, Frances
    Sprengeler, Paul
    Stappenbeck, Frank
    Steensma, Ruo
    Wilson, Mark
    Wong, Melissa
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (01) : 279 - 282
  • [5] Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
    Antonysamy, Stephen S.
    Aubol, Brandon
    Blaney, Jeff
    Browner, Michelle F.
    Giannetti, Anthony M.
    Harris, Seth F.
    Hebert, Normand
    Hendle, Joerg
    Hopkins, Stephanie
    Jefferson, Elizabeth
    Kissinger, Charles
    Leveque, Vincent
    Marciano, David
    McGee, Ethel
    Najera, Isabel
    Nolan, Brian
    Tomimoto, Masaki
    Torres, Eduardo
    Wright, Tobi
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (09) : 2990 - 2995
  • [6] Binding of small molecules to an adaptive protein-protein interface
    Arkin, MR
    Randal, M
    DeLano, WL
    Hyde, J
    Luong, TN
    Oslob, JD
    Raphael, DR
    Taylor, L
    Wang, J
    McDowell, RS
    Wells, JA
    Braisted, AC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) : 1603 - 1608
  • [7] Flipped out: Structure-guided design of selective pyrazolylpyrrole ERK inhibitors
    Aronov, Alex M.
    Baker, Christopher
    Bemis, Guy W.
    Cao, Jingrong
    Chen, Guanjing
    Ford, Pamella J.
    Germann, Ursula A.
    Green, Jeremy
    Hale, Michael R.
    Jacobs, Marc
    Janetka, James W.
    Maltais, Francois
    Martinez-Botella, Gabriel
    Namchuk, Mark N.
    Straub, Judy
    Tang, Qing
    Xie, Xiaoling
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (06) : 1280 - 1287
  • [8] Antihydrophobic solvent effects: An experimental probe for the hydrophobic contribution to enzyme-inhibitor binding
    Bartlett, PA
    Yusuff, N
    Rico, AC
    Lindvall, MK
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (15) : 3853 - 3857
  • [9] NanoStore: A concept for logistical improvements of compound handling in high-throughput screening
    Benson, N
    Boyd, HF
    Everett, JR
    Fries, J
    Gribbon, P
    Haque, N
    Henco, K
    Jessen, T
    Martin, WH
    Mathewson, TJ
    Sharp, RE
    Spencer, RW
    Stuhmeier, F
    Wallace, MS
    Winkler, D
    [J]. JOURNAL OF BIOMOLECULAR SCREENING, 2005, 10 (06) : 573 - 580
  • [10] Using fragment cocktail crystallography to assist inhibitor design of Trypanosoma brucei nucleoside 2-deoxyribosyltransferase
    Bosch, Jurgen
    Robien, Mark A.
    Mehlin, Christopher
    Boni, Erica
    Riechers, Aaron
    Buckner, Frederick S.
    Van Voorhis, Wesley C.
    Myler, Peter J.
    Worthey, Elizabeth A.
    DeTitta, George
    Luft, Joseph R.
    Lauricella, Angela
    Gulde, Stacey
    Anderson, Lori A.
    Kalyuzhniy, Oleksandr
    Neely, Helen M.
    Ross, Jenni
    Earnest, Thomas N.
    Soltis, Michael
    Schoenfeld, Lori
    Zucker, Frank
    Merritt, Ethan A.
    Fan, Erkang
    Verlinde, Christophe L. M. J.
    Hol, Wim G. J.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (20) : 5939 - 5946